Repeatability and reproducibility of prostate apparent diffusion coefficient values on a 1.5 T magnetic resonance linear accelerator

Repeatability and reproducibility of prostate apparent diffusion coefficient values on a 1.5 T magnetic resonance linear accelerator

Background and Purpose: Integrated magnetic resonance linear accelerator (MR-Linac) systems offer potential for biologically based adaptive radiation therapy using apparent diffusion coefficient (ADC). Accurate tracking of longitudinal ADC changes is key to establishing ADC-driven dose adaptation. H...

Full description

Bibliographic Details
Main Authors:	Nitara Fernando, Tony Tadic, Winnie Li, Tirth Patel, Jerusha Padayachee, Anna T. Santiago, Jennifer Dang, Peter Chung, Enrique Gutierrez, Catherine Coolens, Edward Taylor, Jeff D. Winter
Format:	Article
Language:	English
Published:	Elsevier 2024-04-01
Series:	Physics and Imaging in Radiation Oncology
Subjects:	Apparent diffusion coefficient Biomarker Radiation therapy MR-Linac Reproducibility
Online Access:	http://www.sciencedirect.com/science/article/pii/S240563162400040X

Similar Items

Case Report: MR-Guided Adaptive Radiotherapy, Some Room to Maneuver
by: Winnie Li, et al.
Published: (2022-04-01)

Evaluation of Apparent Diffusion Coefficient Repeatability and Reproducibility for Preclinical MRIs Using Standardized Procedures and a Diffusion-Weighted Imaging Phantom
by: Dariya Malyarenko, et al.
Published: (2023-02-01)

Impact of intrafraction changes in delivered dose of the day for prostate cancer patients treated with stereotactic body radiotherapy via MR-Linac
by: Jennifer Dang, et al.
Published: (2022-09-01)

Practice-based training strategy for therapist-driven prostate MR-Linac adaptive radiotherapy
by: Winnie Li, et al.
Published: (2023-09-01)

Quantitative analysis of diffusion weighted imaging in rectal cancer during radiotherapy using a magnetic resonance imaging integrated linear accelerator
by: Manasi Ingle, et al.
Published: (2022-07-01)

Repeatability quantification of brain diffusion-weighted imaging for future clinical implementation at a low-field MR-linac
by: Moritz Rabe, et al.
Published: (2024-03-01)

Feasibility of cardiac-synchronized quantitative T1 and T2 mapping on a hybrid 1.5 Tesla magnetic resonance imaging and linear accelerator system
by: Osman Akdag, et al.
Published: (2022-01-01)

Reproducibility and repeatability of same-day two sequential FDG PET/MR and PET/CT
by: David Groshar, et al.
Published: (2017-04-01)

Dosimetric comparison of MR-linac-based IMRT and conventional VMAT treatment plans for prostate cancer
by: Vanessa Da Silva Mendes, et al.
Published: (2021-07-01)

Online adaptive planning for prostate stereotactic body radiotherapy using a 1.5 Tesla magnetic resonance imaging-guided linear accelerator
by: Jinzhong Yang, et al.
Published: (2021-01-01)

Prospective evaluation of patient-reported anxiety and experiences with adaptive radiation therapy on an MR-linac
by: Amanda Moreira, et al.
Published: (2024-03-01)

Longitudinal monitoring of Apparent Diffusion Coefficient (ADC) in patients with prostate cancer undergoing MR-guided radiotherapy on an MR-Linac at 1.5 T: a prospective feasibility study
by: Almansour Haidara, et al.
Published: (2023-06-01)

Quantitative magnetic resonance imaging on hybrid magnetic resonance linear accelerators: Perspective on technical and clinical validation
by: Daniela Thorwarth, et al.
Published: (2020-10-01)

Online adaptive radiotherapy for head and neck cancers on the MR linear Accelerator: Introducing a novel modified Adapt-to-Shape approach
by: Amit Gupta, et al.
Published: (2022-01-01)

Tumor-site specific geometric distortions in high field integrated magnetic resonance linear accelerator radiotherapy
by: Signe Winther Hasler, et al.
Published: (2020-07-01)

Dosimetric and geometric end-to-end accuracy of a magnetic resonance guided linear accelerator
by: Luisa S. Stark, et al.
Published: (2020-10-01)

Comparison of treatment plans between IMRT with MR-linac and VMAT for lung SABR
by: Jong Min Park, et al.
Published: (2019-06-01)

Short-term repeatability and long-term reproducibility of quantitative MR imaging biomarkers in a single centre longitudinal study
by: Marina Salluzzi, et al.
Published: (2022-10-01)

Comparing multi-image and image augmentation strategies for deep learning-based prostate segmentation
by: Samuel Fransson
Published: (2024-01-01)

Interobserver variation of clinical oncologists compared to therapeutic radiographers (RTT) prostate contours on T2 weighted MRI
by: Gillian Adair Smith, et al.
Published: (2023-03-01)

The MRI-Linear accelerator (MR-linac) Consortium: evidence based clinical introduction of an innovation in radiation oncology connecting researchers, methodology, data collection, quality assurance and technical development
by: Linda G.W. Kerkmeijer, et al.
Published: (2016-10-01)

MRI-Guided Online Adaptive Stereotactic Body Radiation Therapy of Liver and Pancreas Tumors on an MR-Linac System
by: Teo Stanescu, et al.
Published: (2022-01-01)

MR-Guided Adaptive Radiotherapy for Bladder Cancer
by: Adham Hijab, et al.
Published: (2021-02-01)

Feasibility of tumour-focused adaptive radiotherapy for bladder cancer on the MR-linac
by: A. Mitchell, et al.
Published: (2022-07-01)

Feasibility of magnetic resonance guided radiotherapy for the treatment of bladder cancer
by: A. Hunt, et al.
Published: (2020-11-01)

Dose accumulation for MR-guided adaptive radiotherapy: From practical considerations to state-of-the-art clinical implementation
by: Brigid A. McDonald, et al.
Published: (2023-01-01)

Impact of magnetic resonance-guided versus conventional radiotherapy workflows on organ at risk doses in stereotactic body radiotherapy for lymph node oligometastases
by: Anita M. Werensteijn-Honingh, et al.
Published: (2022-07-01)

Deep learning application for abdominal organs segmentation on 0.35 T MR-Linac images
by: You Zhou, et al.
Published: (2024-01-01)

First multicentre experience of SABR for lymph node and liver oligometastatic disease on the unity MR-Linac
by: Tomas M. Janssen, et al.
Published: (2022-06-01)

Patient-Reported Tolerance of Magnetic Resonance-Guided Radiation Therapy
by: Mutlay Sayan, et al.
Published: (2020-09-01)

1.5 T MR-linac planning study to compare two different strategies of rectal boost irradiation
by: Pierluigi Bonomo, et al.
Published: (2021-01-01)

Repeatability of MRI for radiotherapy planning for pelvic, brain, and head and neck malignancies
by: Monique Y. Heinke, et al.
Published: (2022-12-01)

Stereotactic body radiotherapy of central lung tumours using a 1.5 T MR-linac: First clinical experiences
by: L.G. Merckel, et al.
Published: (2024-03-01)

Clinical application of MR-Linac in tumor radiotherapy: a systematic review
by: Xin Liu, et al.
Published: (2023-03-01)

Analysis of data to Advance Personalised Therapy with MR-Linac (ADAPT-MRL)
by: Jeremiah de Leon, et al.
Published: (2021-11-01)

Ventilation and perfusion MRI at a 0.35 T MR-Linac: feasibility and reproducibility study
by: Rabea Klaar, et al.
Published: (2023-04-01)

First Experience and Prospective Evaluation on Feasibility and Acute Toxicity of Online Adaptive Radiotherapy of the Prostate Bed as Salvage Treatment in Patients with Biochemically Recurrent Prostate Cancer on a 1.5T MR-Linac
by: Daniel Wegener, et al.
Published: (2022-08-01)

Effect of 0.35 T and 1.5 T magnetic fields on superficial dose in MR-guided radiotherapy of laryngeal cancer
by: Mireille Conrad, et al.
Published: (2023-05-01)

Synthetic computed tomography for low-field magnetic resonance-guided radiotherapy in the abdomen
by: Mariia Lapaeva, et al.
Published: (2022-10-01)

1.5T MR-Guided Daily Adaptive Stereotactic Body Radiotherapy for Prostate Re-Irradiation: A Preliminary Report of Toxicity and Clinical Outcomes
by: Francesco Cuccia, et al.
Published: (2022-04-01)